About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Ind-Swift Laboratories Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
532305
ISIN Demat
INE915B01019
Book Value
171.13
NSE Code
INDSWFTLAB
Dividend Yield %
0.00
Market Cap
8569.21
P/E
3.71
EPS
28.32
Face Value
10
BSE
NSE
08-Sep-2025 11:45
BSE
NSE
NSE F & O
08-Sep-2025 11:38
BSE
NSE
NSE F & O
Last Price
103.00
Net Change
1
% Change
0.98%
Prev.Close
102.00
Open
102.00
High
106.00
Low
101.00
Volume
4245
Last Price
104.35
Net Change
2.3
% Change
2.25%
Prev.Close
102.05
Open
103.05
High
106.00
Low
101.50
Volume
62669
Value
437235
Best Buy
103.10
Best Sell
105.80
Best Quantity
50
Sell Quantity
50
Today's Range
106.00
52-Week High
154.55
52-Week Low
67.15
Value
6539510.15
Best Buy
103.35
Best Sell
104.35
Best Quantity
1929
Sell Quantity
252
Today's Range
106.00
52-Week High
155.00
52-Week Low
68.72
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
50
Price
103.10
Quantity
50
Price
105.80
Best Bid
Best Offer
Quantity
1929
Price
103.35
Quantity
252
Price
104.35
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
25-Sep-24
30-Sep-24
Dividend
10 %
22-Sep-11
Company News
25-07-2025
Ind-Swift Laboratories i...
04-07-2025
Ind-Swift Laboratories in...
21-06-2025
Ind-Swift Laboratories in...
22-01-2025
Ind-Swift Laboratories in...
04-01-2025
IND-Swift Laboratories in...
02-01-2025
Ind-Swift Laboratories pu...
10-12-2024
Ind-Swift Laboratories sh...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.